Skip to content

Clinical trials

Observational Burkitt Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Observational Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20051
20064
20072
20087
20095
20102
20121
20131
20161
20171
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated8
Recruiting7
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Vanderbilt-Ingram Cancer Center4
City of Hope Medical Center3
Case Comprehensive Cancer Center2
Fred Hutchinson Cancer Center2
Mayo Clinic2
Medical College of Wisconsin2
SWOG Cancer Research Network2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
UNC Lineberger Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma40
Lymphoma, Large B-Cell, Diffuse33
Lymphoma30
Precursor Cell Lymphoblastic Leukemia-Lymphoma30
Lymphoma, Follicular28
Lymphoma, Non-Hodgkin28
Lymphoma, Large-Cell, Immunoblastic27
Lymphoma, Mantle-Cell27
Leukemia, Lymphocytic, Chronic, B-Cell26
Lymphoma, B-Cell, Marginal Zone25

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.